Internal Medicine
| 4 min read
From layoffs at the FDA, CDC, and NIH to a blood test for Alzheimer’s disease and a starfish-inspired diagnostic, the DDN team breaks down this week’s news.
| 4 min read
A landmark UTI drug approval, new hope for the amyloid hypothesis in Alzheimer’s disease, a brewing vaccine study controversy, and more led the news this week.
| 2 min read
Antibiotics target bacteria, but new work in mice shows they also harm the mucus layer that protects the intestinal lining from microbes.
| 5 min read
From advances in graft versus host disease treatment to updates on H5N1 and Duchenne muscular dystrophy research, the DDN editors break down the news this week.
| 8 min read
Virus-inspired delivery methods enable gene editing of dysregulated microbes.
| 3 min read
Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
| 4 min read
DDN editors break down a surprising connection between microplastics and antimicrobial resistance, vitamin D for multiple sclerosis, obesity drugs updates, and more news from this week.
| 10+ min read
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.
| 6 min read
Sabrina Johnson at Daré Bioscience is redefining contraception with Ovaprene, a non-hormonal, monthly option for safe and effective birth control.
| 3 min read
A close encounter with a venomous critter sparked insight for communicating science in times of stress.
| 4 min read
Xaira Therapeutics is leveraging novel generative AI models to design medicines for diseases without treatments.
| 2 min read
Using a sheep model, researchers developed an injectable biomaterial that interacts with nearby cells and recruits them to make new cartilage.
